# Cold Urticaria Treatment With Xolair

> **NCT01580592** · PHASE2 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 31 (actual)

## Conditions studied

- Cold Contact Urticaria

## Interventions

- **DRUG:** Omalizumab
- **DRUG:** Omalizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01580592
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580592, "Cold Urticaria Treatment With Xolair". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01580592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*